Skip to main content

Special Issues Archive

All previous special issues and supplements of Oncology Practice Management are available here. Browse the digital archive below or use the search page to find a specific article you're looking for.

2022 Year in Review: Cholangiocarcinoma

Faculty Perspectives: Optimizing Clinical Outcomes and Value-Based Management in Multiple Myeloma—The Role of Isatuximab
For this supplement, the expert faculty provided detailed perspectives on the evolving role of isatuximab in the multiple myeloma treatment paradigm, including their point of view on recent data from the phase 3 GMMG HD7 study and the cost implications for the use of isatuximab-based regimens in myeloma, along with their overall impressions of the current costs of myeloma care and treatment. Read More ›

Best Practices: Immune-Related Adverse Event Management in Patients with Advanced NSCLC Treated with  Immune Checkpoint Inhibitors

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

2022 Midyear Review: Non–Small-Cell Lung Cancer

Faculty Perspectives: The Evolving Clinical and Pharmacoeconomic Impact of Isatuximab in Multiple Myeloma Management
For this supplement, the expert faculty provided detailed perspectives on the evolving role of isatuximab in the multiple myeloma treatment paradigm, including their point of view on recent data from the phase 3 GMMG HD7 study and the cost implications for the use of isatuximab-based regimens in myeloma, along with their overall impressions of the current costs of myeloma care and treatment. Read More ›

Best Practices: Practical Guidance in Treating Advanced NSCLC with Immunotherapy

2021 Year in Review - Ovarian Cancer

2021 Year in Review - Multiple Myeloma

2022 Oncology Biosimilar Guide to Patient Support Services

Page 2 of 6